PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Hospices Civils de Lyon250 enrolled

Overview

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Severe Infection

Interventions

Description of severe infectionOTHER

Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033 * PHAGEinLYON Clinic cohort study information notice provided to the patient Exclusion Criteria: * Opposition of trial participant

Locations (1)

Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon

Lyon, France

RECRUITING

Outcomes

Primary Outcomes

Rate of each type of severe infection

Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Time frame: through study completion (5years)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.